Shafiqur Rahman

Prof. Dr. Shafiqur Rahman

Pharmaceutical Sciences, South Dakota State University, Brookings, Oregon, USA
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PDF file
RSRavi K Sajja
Ravi K Sajja
Shafiqur RahmanShafiqur Rahman
Shafiqur Rahman
Luca CuculloLuca Cucullo
Luca Cucullo
Psychostimulants and nicotine are the most widely abused drugs with a detrimental impact on public health globally. While the long-term neurobehavioral deficits and synaptic perturbations are well documented with chronic use of methamphetamine, cocaine, and nicotine, emerging human and experimental studies also suggest an increasing incidence of neurovascular complications associated with drug abuse. Short- or long-term administration of psychostimulants or nicotine is known to disrupt blood-brain barrier (BBB) integrity/function, thus leading to an increased risk of brain edema and neuroinflammation. Various pathophysiological mechanisms have been proposed to underlie drug abuse-induced BBB dysfunction suggesting a central and unifying role for oxidative stress in BBB endothelium and perivascular cells. This review discusses drug-specific effects of methamphetamine, cocaine, and tobacco smoking on brain microvascular crisis and provides critical assessment of oxidative stress-dependent molecular pathways focal to the global compromise of BBB. Additionally, given the increased risk of human immunodeficiency virus (HIV) encephalitis in drug abusers, we have summarized the synergistic pathological impact of psychostimulants and HIV infection on BBB integrity with an emphasis on unifying role of endothelial oxidative stress. This mechanistic framework would guide further investigations on specific molecular pathways to accelerate therapeutic approaches for the prevention of neurovascular deficits by drugs of abuse.

1 January 2004 in Neuroscience
Verified
Journal Article
Closed access
Shafiqur RahmanShafiqur Rahman
Shafiqur Rahman
JZJ. Zhang
J. Zhang
EEE.A. Engleman
E.A. Engleman
WCW.A. Corrigall
W.A. Corrigall

1 January 1997 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Shafiqur RahmanShafiqur Rahman
Shafiqur Rahman
PLPeter P. Li
Peter P. Li
LYL. Trevor Young
L. Trevor Young
OKOra Kofman
Ora Kofman
SKStephen J. Kish
Stephen J. Kish
JWJerry J. Warsh
Jerry J. Warsh
Findings of increased Gsα levels and forskolin‐stimulated adenylyl cyclase activity in selective cerebral cortical postmortem brain regions in bipolar affective disorder (BD) implicate increased cyclic AMP (cAMP)‐mediated signaling in this illness. Accumulating evidence suggests that intracellular levels of cAMP modulate the abundance and disposition of the regulatory subunits of cAMP‐dependent protein kinase (cAMP‐dPK). Thus, in the present study, we tested further whether hyperfunctional Gsα‐linked cAMP signaling occurs in BD by determining [3H]cAMP binding, a measure of the levels of regulatory subunits of cAMP‐dPK, in cytosolic and membrane fractions from discrete brain regions of postmortem BD brain. Specific [3H]cAMP (5 nM) binding was determined in autopsied brain obtained from 10 patients with DSM‐III‐R diagnoses of BD compared with age‐ and postmortem delay‐matched controls. [3H]cAMP binding was significantly reduced across all brain regions in cytosolic fractions of BD frontal (−22%), temporal (−23%), occipital (−22%) and parietal (−15%) cortex, cerebellum (−36%), and thalamus (−13%) compared with controls, but there were no differences in [3H]cAMP binding in the membrane fractions from these same regions. These results suggest that changes occur in the cAMP‐dPK regulatory subunits in BD brain, possibly resulting from increased cAMP signaling. The possibility that antemortem lithium and/or other mood stabilizer treatment may contribute to the above changes, however, cannot be ruled out.


1 February 1993 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Shafiqur RahmanShafiqur Rahman
Shafiqur Rahman
RNRichard S. Neuman
Richard S. Neuman

1 January 2016
Verified
Book Chapter
Closed access
RBRichard Bell
Richard Bell
SHSheketha R. Hauser
Sheketha R. Hauser
JMJeanette McClintick
Jeanette McClintick
Shafiqur RahmanShafiqur Rahman
Shafiqur Rahman
HEHoward J. Edenberg
Howard J. Edenberg
WMWilliam J. McBride
William J. McBride